β-1,3 葡萄糖微粒和纳米颗粒:制造方法和在免疫调节和向药物输送中的应用
1Department of Chemical Engineering, McMaster University, 1280 Main St W, Hamilton, Ontario, L8S 4L8, Canada.
Advanced healthcare materials
|April 30, 2025
概括
这篇评论探讨了beta-1,3葡萄糖颗粒用于调节免疫细胞的作用. 这些粒子为治疗应用提供了一个有希望的策略,用于逆转先天性免疫细胞中促进疾病的表型.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 天生的免疫细胞,如巨细胞和树突细胞,驱动癌症,纤维化和自身免疫疾病的疾病进展.
- 环境因素可以改变免疫细胞表型,加剧疾病状态.
- 正在开发免疫调节材料来重新编程这些促病免疫细胞表型.
研究的目的:
- 审查beta-1,3葡萄糖衍生的微粒和纳米颗粒的制造技术.
- 讨论如何通过葡萄糖化学,制造和配方调整粒子特性.
- 为了突出beta-1,3葡萄糖颗粒在疾病治疗中的免疫调节应用.
主要方法:
- 关于制造β-1,3葡萄糖颗粒的文献综述.
- 分析影响粒子特性 (化学,制造,配方) 的因素.
- 讨论免疫细胞向,调制和治疗治疗中的应用.
主要成果:
- 各种制造方法可以产生具有可调节性质的β-1,3葡萄糖微粒和纳米颗粒.
- β-1,3葡萄糖颗粒对天生的免疫细胞表现出多种免疫调节作用.
- 通过调整葡萄糖化学和配方,可以精确控制颗粒的特性.
结论:
- β-1,3葡萄糖颗粒代表了免疫调节的多功能平台.
- 这些颗粒可以被设计为有针对性的输送和治疗疗效.
- 利用葡萄糖颗粒的可塑性为治疗免疫相关疾病提供了一种新的方法.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...